Tetanos Quick Stick

Tetanos Quick Stick

This method uses a combination of tetanus toxoid coated on the solid phase and a mixture of colloidal gold conjugates including tetanus toxoid-dye conjugate.

The blood, serum or plasma is deposited into the TQS sample well. A diluent is then added to the same well. The diluent flows through the absorbent pad, carrying the toxoid-dye conjugate along the chromatographic strip, forming a complex with the anti-tetanus immunoglobins present in the sample. This complex reacts with the immobilized toxoid in the “ T” zone to form a color band.

The excess gold conjugate binds to a control reagent immobilized in the “C” zone, forming a pink band and confirming that the test has been carried out correctly.

When and why should I use Tetanos Quick Stick (TQS)?

• For every patient presenting with a tetanus prone
• To estimate the vaccination status of your patients
• To make the correct informed decision

Traceability of the result

2 labels for traceability per test are supplied in each kit for the purpose of:.

• Identification of both the batch and the patient
• Traceability of the result.

Simplified Protocol

• Pierce the skin with the provided lancet
• Put the pipette horizontally into the drop of blood. Don’t squeeze the pipette during the pipeting, the blood will go through capillarity until it reaches the black line.
• Hold the pipette vertically above the sample wells, put 2 fingers on the black line and press to release the total volume of blood.
• Add 3 drops of diluent.
• Read the result at 10 minutes.

TQS - Frequently Asked Questions

What is the storage temperature?

The storage temperature is between +4C and +30C.

What is the sensitivity and specificity of the test?

How do I you know that my test result is accurate?

• According to WHO standard, TQS has been evaluated with different concentrations of anti-tetanus antibodies (0,025 to 100 IU/ml).
• No interference observed with high rates of bilirubin, hemoglobin, albumin and cholesterol or the presence of rheumatoid factor.
• Validation of the test was performed by comparison to Elisa test. Evaluation on 865 samples: 289 samples of whole blood, 287 samples of plasma and 289 samples of serum.